Close
  Indian J Med Microbiol
 

Figure 2: Mean of studied clinical variables, symptom severity scale and functional status scale, at baseline and 4 and 12 weeks after interventions in group A (splint) and group B (splint + steroid) (P < 0.001 due to the significant differences between baseline and 4 weeks after intervention and baseline and 12 weeks after intervention) (not significant between 4 and 12 weeks after intervention). FSS: Functional status scale, SSS: Symptom severity scale

Figure 2: Mean of studied clinical variables, symptom severity scale and functional status scale, at baseline and 4 and 12 weeks after interventions in group A (splint) and group B (splint + steroid) (<i>P</i> < 0.001 due to the significant differences between baseline and 4 weeks after intervention and baseline and 12 weeks after intervention) (not significant between 4 and 12 weeks after intervention). FSS: Functional status scale, SSS: Symptom severity scale